This report reveals the results of formative research conducted to fill gaps in understanding of caregivers’ infant and young child feeding practices, following on the results of the 2007 Zambia Demographic and Health Survey. In particular, the study explores factors that influence a mother’s ability to exclusively breastfeed for the first six months of an infant’s life and factors that influence appropriate complementary feeding for children 6–23 months of age.

Publication date: December 2010

Region: Global

PATH is creating a broad portfolio of rice fortification technologies as well as ancillary technologies to ensure effective integration of fortified grains into rice supply chains. This document provides a list of fortified grain producers around the world.

Publication date: December 2012

Region: Global

This case study highlights PATH's work with the Global Alliance for Improved Nutrition and the Naandi Foundation to introduce rice fortified with iron-enriched grains into the government of India's Mid-day Meal Scheme in Vishakhapatnam, Andhra Pradesh. The fortified rice was served daily for one school year to 60,000 children under the government-sponsored Mid-day Meal Scheme. A peer-reviewed study found that school children in India between the ages of 5 and 12 years who ate fortified rice had a significant increase in iron stores.

Publication date: July 2009

Region: Global

This fact sheet provides information about using time temperature indicators to monitor heat exposure of oxytocin, a common drug used to prevent and treat postpartum hemorrhage.

Publication date: May 2014

Region: Global

Part of the Technology Updates series, this fact sheet describes the gentamicin in Uniject project at PATH.

Publication date: May 2012

Region: Global

Part of series: Technology Updates

These studies aim to provide ministries of health and their partners with data about the actual practice of active management of the third stage of labor (AMTSL), including policy, provider support, and supplies and logistics, along with the descriptive information necessary to assess AMTSL practices and identify barriers to its use in their country.

Publication date: 2006

Region: Global

This website about the technologies for maternal and neonatal health group within the Technology Solutions program provides an overview of the group and its featured projects. See other PATH program websites.

Publication date: 2014

Region: Global

Part of series: Program websites

This compilation contains key references and resources to aid program planners in the introduction of oxytocin in the Uniject™ prefilled injection device.

Publication date: October 2009

Region: Global

This report details a study of willingness to pay for oxytocin in the Uniject™ injection system among private midwives in Indonesia. The study also helped to reveal the preferred brands and use of oxytocin, assess the perception of oxytocin in Uniject™ with or without a time-temperature indicator, and identify possible challenges and barriers to market introduction and adoption of oxytocin in Uniject™ in Indonesia.

Publication date: October 2011

Region: Asia

The UN Commission on Life-Saving Commodities for Women and Children was launched in 2012 to increase access to lifesaving commodities in the world's poorest countries, and neonatal resuscitation devices were selected as one of the lifesaving commodities. The objective of PATH’s market sizing is to estimate the total market size for newborn resuscitation commodities in eight African countries. The market size estimates reflect the total number of commodities each country will need to provide resuscitation care to newborns born in facilities.

Publication date: January 2014

Region: Global

This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

Publication date: July 2011

Region: Global

A Healthy Dose from PATH’s Drug Development program gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development.

Publication date: 2014

Region: Global

Part of series: E-newsletters

This document describes the work of the Khusela project, which focuses on integrating services for family planning, reproductive health, and prevention of mother-to-child transmission of HIV.

Publication date: March 2010

Region: Africa

Overview of the ASUH (Healthy Start for a Healthy Life) program in Indonesia.

Publication date: 2003

Region: Asia

Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This two-page success story profiles a volunteer health worker who learned about the benefits of good breastfeeding practices during an Infant and Young Child Nutrition Project training workshop in rural Lesotho. The story highlights the project’s work to improve nutrition for infants and young children in developing countries by training community volunteers who counsel mothers on optimal nutrition practices.

Publication date: December 2008

Region: Global

Author: Younger E; Wittet S; Hooks C; Lasher H

Publication date: 2001

Region: Global

Globally, the leading cause of maternal death is postpartum hemorrhage (PPH). In the absence of a skilled birth attendant, the World Health Organization recommends that a uterotonic drug, preferably oxytocin, be given to prevent PPH. This fact sheet describes how oxytocin in the Uniject™ injection system is one of the tools that programs in Latin America can use to expand access to oxytocin for prevention and treatment of PPH.

Publication date: October 2011

Region: Latin America

This is a handout of a poster presented at the International AIDS Conference in Vienna, Austria, in July 2010. The document presents evidence concerning the effect of breastfeeding avoidance and early cessation on child mortality and HIV-free survival in developing countries.

Publication date: July 2010

Region: Global

This is one of a series of fact sheets that describe PATH's current and past work in Kenya. The fact sheets focus on specific projects as well as unique approaches that cut across projects. This fact sheet describes work to improve single-dose packaging of nevirapine for programs to prevent mother-to-child transmission of HIV.

Publication date: July 2006

Region: Africa